Astera Labs Reports Record Q1 Revenue and Strong Earnings, Projects Continued Growth in Q2
summarizeSummary
Astera Labs reported record first-quarter 2026 revenue of $308.4 million, up 93% year-over-year, with GAAP diluted EPS of $0.44, and provided strong second-quarter revenue guidance of $355 million to $365 million.
check_boxKey Events
-
Record Q1 Revenue Reported
Astera Labs achieved record quarterly revenue of $308.4 million for Q1 2026, representing a 14% sequential increase and a 93% year-over-year increase, driven by strong demand for its PCIe 6 portfolio.
-
Strong Q1 Earnings Performance
The company reported GAAP net income of $80.3 million and GAAP diluted net earnings per share of $0.44 for the first quarter. Non-GAAP diluted net earnings per share reached $0.61.
-
Positive Q2 Revenue Guidance
For the second quarter of fiscal 2026, Astera Labs estimates revenue to be within a range of $355 million to $365 million, indicating continued growth.
-
Q2 EPS Guidance Provided
The company projects GAAP diluted earnings per share for Q2 2026 to be approximately $0.44 to $0.46, with non-GAAP diluted earnings per share expected between $0.68 and $0.70.
auto_awesomeAnalysis
Astera Labs delivered robust first-quarter financial results, driven by strong demand for its PCIe 6 portfolio and AI infrastructure solutions. The company achieved record revenue with significant year-over-year growth, demonstrating strong execution in a critical market. The positive outlook for the second quarter, including increased revenue guidance, suggests continued momentum. Strategic product developments, such as the shipment of the Scorpio X-Series AI Fabric switch and expansion of the Scorpio P-Series, position Astera Labs for sustained growth in the rapidly expanding AI sector. This performance underscores the company's leadership in semiconductor-based connectivity solutions for rack-scale AI.
At the time of this filing, ALAB was trading at $218.11 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $36.7B. The 52-week trading range was $63.40 to $262.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.